ADC Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.928; its P/E ratio is -1.70; ADC Therapeutics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	-	$ 76.32M	$ 17.29M	$ 46.50M	$ 17.01M
Gross Profit	-	$ 75.03M	$ 15.03M	$ 45.97M	$ 16.24M
EBIT	-	$ -39.96M	$ -56.52M	$ -8.61M	$ -46.83M
EBITDA	-	$ -39.39M	$ -55.93M	$ -8.02M	$ -46.07M
Net Income Common Stockholders	-	$ -50.61M	$ -64.37M	$ -16.66M	$ -34.38M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 31.15M	$ 380.86M	$ 376.78M	$ 430.87M	$ 466.54M
Total Assets	$ 529.17M	$ 531.76M	$ 520.46M	$ 581.89M	$ 617.97M
Total Debt	$ 7.66M	$ 116.66M	$ 103.32M	$ 124.65M	$ 139.70M
Net Debt	$ -23.49M	$ -264.20M	$ -273.46M	$ -306.22M	$ -326.85M
Total Liabilities	$ 440.44M	$ 426.98M	$ 405.12M	$ 419.22M	$ 451.88M
Stockholders Equity	$ -73.91M	$ 104.78M	$ 115.35M	$ 162.67M	$ 166.09M
Cash Flow	-
Free Cash Flow	-	$ 1.94M	$ -53.82M	$ -35.00M	$ -62.16M
Operating Cash Flow	-	$ 2.19M	$ -53.01M	$ -33.88M	$ -61.63M
Investing Cash Flow	-	$ -254.00K	$ -689.00K	$ -1.45M	$ -830.00K
Financing Cash Flow	-	$ 2.37M	$ -252.00K	$ -258.00K	$ -1.22M

Currency in USD

ADC Therapeutics Earnings and Revenue History

Income Statement >

ADC Therapeutics Debt to Assets

Balance Sheet >

ADC Therapeutics Cash Flow

Cash Flow >

ADC Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing